Stay updated on Avelumab and Palbociclib in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.

Latest updates to the Avelumab and Palbociclib in Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedThe record history now includes revision v3.5.2 and removes revision v3.5.0. This is a metadata update to the history log rather than substantive study information.SummaryDifference0.1%

- Check10 days agoChange DetectedThe PALAVY study record title was updated to 'Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY)'. The update also adds IPDSharing, Study Status, and Study Identification fields, replacing the prior title variant.SummaryDifference0.7%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.5.0 was added to the Record History. Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision v3.4.3 was added to the Study Record Versions, and revision v3.4.2 was removed.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry v3.4.2 was added to the history and v3.4.1 was removed from the list.SummaryDifference0.1%

- Check75 days agoChange DetectedThe record history now includes revision v3.4.1 and removes v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Avelumab and Palbociclib in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.